New research shows that retinal neurons can rewire to preserve vision in retinitis pigmentosa, a genetic disease causing blindness.

AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...

Similar data from Social Security Scotland indicates there are now 2,010 people receiving ADP for an eye condition. An estimated 188,000 people in Scotland are affected by some form of sight loss with ...

Meanwhile, the DVLA has also warned drivers that they risk fines of up to £1,000 and points on their licence if they fail to ...

Charles Bonnet Syndrome (CBS) is a rare visual condition causing vivid hallucinations, often seen in those with eye disorders.

Medical device steriliser Nanosonics is pushing for stronger sales of its flagship device Trophon, ahead of the release of an ...

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

Newer techniques using nanoparticles are less invasive, but some need bright visible light, which can harm any remaining ...

The global retinitis pigmentosa market, valued at $11.31 billion in 2024, is expected to grow to $25.87 billion by 2034, driven by gene therapy advancements, aging populations, and strategic ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain ...

Female sex hormones can significantly enhance the progression of the rare neurodegenerative eye disease retinitis pigmentosa (RP), according to a preclinical study by researchers at UT Southwestern ...